Industries > Pharma > Global Oncology Pricing, Reimbursement & Market Access 2019-2029

Global Oncology Pricing, Reimbursement & Market Access 2019-2029

US, Canada, Germany, France, UK, Italy, Spain, Japan, Australia, Brazil, Russia, India, China

PUBLISHED: 10 September 2019
PAGES: 292
PRODUCT CODE: PHA0522
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0522 Categories: , Tags: , ,

The global oncology pricing, reimbursement and market access report provides analysis and evaluation of the current and prospective economic burden of cancer treatment in the US, Canada, Germany, France, UK, Italy, Spain, Japan, Australia, Brazil, Russia, India, China. This report also outlines historical and current healthcare status for the selected markets with respect to expenditures along with the healthcare system that governs medical access.

In this report, we provide comprehensive view on some of the trends for top-seller oncology drugs including payer’s perspective on cancer outcomes, impact of these high cost drugs, standard guidelines preferred for different cancers, availability and costs of oncology therapeutics and complexity in cancer treatments as well as epidemiology of different cancer types.

How this report will benefit you
In this brand new 292-page report you will receive 98 charts– all unavailable elsewhere.

The 292-page report provides clear detailed insight into the global oncology pricing, reimbursement & market access. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Key questions answered by this report:
• Factors Affecting Pricing and Reimbursement Decision
• Pricing Negotiations and Discounts
• Reimbursement Policies
• Role of HEOR and Economic Value Planning
• Drug Patent Expiry and Effects on Pricing
• Cost-Effectiveness Analysis

• This report discusses healthcare system, pricing & reimbursement process, HTA, oncology cost of treatment, payer insights, healthcare expenditure, health coverage, key formularies, role of pharmacists, regulatory & approval process for these countries:
• United States
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• Australia
• Brazil
• Russia
• India
• China

• Discussion on parallel import and its impact in the US and Europe.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Oncology Pricing, Reimbursement and Market Access. You find data, trends and predictions.

Buy our report today Global Oncology Pricing, Reimbursement & Market Access 2019-2029: US, Canada, Germany, France, UK, Italy, Spain, Japan, Australia, Brazil, Russia, India, China.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Oncology Pricing, Reimbursement & Market Access 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Oncology Pricing, Reimbursement & Market Access 2019-2029


Latest Pharma news

Visiongain Publishes Microcarrier Market Report 2021-2031

In the pharmaceutical industry, cell culture is progressively becoming a noticeable part of vaccine production. Previously, vaccines were manufactured by growing and harvesting viruses in chicken eggs, which was a time-consuming process. In this concern, cell-based vaccine production has developed as a far more efficient method due to its shortened lead-time and the capability to produce vaccines in larger quantities as per demand.

29 October 2020

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Meningococcal diseases is caused by a type of bacteria, it can lead to an infection of the bloodstream or meningitis, or both, and can be life taking if not quickly treated. The meningococcal conjugate vaccines are very affective at protecting against four strains of the bacteria while the MenB vaccine protects against a fifth strain.

29 October 2020

READ

Visiongain Publishes Inspection Machine Market Report 2021-2031

Supervisory obligations in the healthcare industry to sustain compliance with good manufacturing practices, growing number of inspection frontiers in production lines, growing number of product evokes, rising dispersion of automated inspection systems in the pharmaceutical & biotechnology industries, and technological advancement in inspection systems are the major aspects driving the growth of this market.

29 October 2020

READ

Visiongain Publishes Hydrophobic Interaction Chromatography Market Report 2021-2031

Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.

29 October 2020

READ

Categories

Category